T. Macarulla Mercadé

机构：Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari

发表论文 126 篇 · 总被引 1933 次 · h-index 15

代表论文

262MO Preliminary efficacy outcomes of ivosidenib in patients with IDH1-mutated cholangiocarcinoma (mIDH1 CCA): Initial results from the phase IIIb ProvIDHe study (2025 · Annals of Oncology · 被引 5)
CD40 agonist mitazalimab with mFOLFIRINOX in untreated metastatic pancreatic cancer: Biomarkers associated with outcomes from OPTIMIZE-1 (2025 · Cell Reports Medicine · 被引 3)
384TiP Quemliclustat and chemotherapy in previously untreated patients with metastatic pancreatic ductal adenocarcinoma: PRISM-1, a randomized, placebo-controlled, phase III trial (2025 · Annals of Oncology · 被引 3)
2216MO VIRAGE trial: Randomized phase IIb, open-label, study of nab-paclitaxel and gemcitabine with/without intravenous VCN-01 in patients with metastatic pancreatic cancer (mPDAC) (2025 · Annals of Oncology · 被引 2)
320P First-line therapy (1L) of cisplatin/gemcitabine (CisGem) with pembrolizumab (pembro) in patients with advanced biliary tract cancer (aBTC): Open-label, single-arm phase II EORTC-1607-GITCG/ABC-09 intergroup study with translational research (TR) (2025 · Annals of Oncology · 被引 2)
2223P First-line (1L) AZD0171 + durvalumab (D) + chemotherapy (CT) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC): Phase II study results (2025 · Annals of Oncology · 被引 1)